Print
Email
Print Edition StoriesTuesday, March 9, 2010
Orthopaedic Synergy to buy Praxim
By Mass High Tech staff
MHT's Julie Donnelly: Biotechs lag in social media use
MHT talks with Tanja Dominko, WPI researcher and CellThera president
Funding drugs for rare diseases
East Taunton-based Orthopaedic Synergy Inc. has signed a letter of intent to acquire Praxim SA, a French developer of software and instruments used for joint arthoplasty by surgeons. The acquisition is expected to add computer and robotic assisted surgery technology to the company’s offerings.
Formed in January 2009, Orthopaedic Synergy is a holding company for OMNIlife Science Inc. of Raynham and Enztec Ltd. of New Zealand.
“We look forward to watching OMNI, Enztec and Praxim work under the Orthopaedic Synergy banner to enhance our technology offerings as well as dramatically increase the profile and acceptance of our highly advanced proprietary computer and robotic assisted surgical techniques in orthopaedic joint replacement surgery,” said Christian Joly, CEO of Praxim.
No financial terms of the acquisition deal were disclosed.
Orthopaedic Synergy raised $4.8 million in a Series A financing in early 2009, with initial funding coming from Pioneer Capital Partners of Auckland, New Zealand, and the remainder of the financing expected from Birnie Capital Partners, also of Auckland, New Zealand.
OSI officials said in 2009 that the company intends to go public after worldwide financial markets have settled down.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
